Aiforia Technologies Plc, Press Release, April 24, 2024 at 09:00 a.m. EEST A global leader in veterinary health and innovative diagnostic devices, based in the United States, has selected Aiforia Technologies Plc as its partner for AI-assisted image analysis in animal samples. The total value of the contract is approximately USD 200 thousand ..read more

What is veterinary pathology? Veterinary pathology is a multifaceted field within veterinary medicine that focuses on diagnosing diseases in animals. This discipline is foundational for maintaining animal health and, by extension, human health. Veterinary pathology encompasses diagnostic, research, and preclinical facets, each serving a critical role in understanding and managing animal diseases ..read more

Aiforia Technologies Plc, Press Release, March 6, 2024 at 09:00 a.m. EET ..read more

Why Ki-67? Although it is an important biomarker in oncology (mostly in breast and prostate), Ki-67 immunohistochemistry (IHC) analysis has yet to be standardized. Working groups have provided guidelines for Ki-67 scoring in different cancer types to limit pathologist’s variability.¹‚² AI solutions to assist scoring have recently emerged in the evaluation of Ki-67 as rapid and robust solutions. In this study, we compared the results of Ki-67 scoring performed with Aiforia® Platform (deep learning AI platform) against three independent pathologists on various solid tumors ..read more

Aiforia Technologies Plc, Press release, January 2, 2024 at 10.00 a.m. EET Aiforia has entered into an exclusive licensing agreement with the Mayo Clinic in the United States to globally commercialize an AI model that improves prediction of colorectal cancer recurrence. The AI model was developed in collaboration with the Mayo Clinic. The AI model identifies important histological features of colorectal cancer and provides a recurrence prediction estimate useful for colorectal cancer treatment decisions.   ..read more

Dear customers, shareholders, and our team, As we stand at the threshold of a new year, I wanted to take a moment to review the events of 2023 and express my gratitude for your continued support and hard work that the team has done. It has been a year of important milestones for Aiforia as the first deployments of our clinical AI-solutions were kicked-off in key markets ..read more

Aiforia Technologies Plc, Press Release, October 20, 2023 at 10:00 a.m. EEST ..read more

Aiforia Technologies Plc, Press Release, 18 September 2023 at 09:00 a.m. EEST ..read more

Aiforia Technologies Plc, Press Release, 05 July 2023 at 12:00 a.m. EEST ..read more

Aiforia Technologies Plc  Inside information 29 June 2023 at 10:30 a.m. EEST ..read more